Ingrid Goldberg | executive |
William Doyle | executive |
Asaf Danziger | executive |
Ashley Cordova | executive |
Jonathan Chang | analyst |
Uri Weinberg | executive |
Lei Huang | analyst |
Pritesh Shah | executive |
Emily Bodnar | analyst |
Welcome to the NovoCure Q3 2023 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Ingrid Goldberg. Please go ahead.
Good morning, and thank you for joining us to review NovoCure's third quarter 2023 performance. I'm on the phone this morning with our Executive Chairman, Bill Doyle; our CEO, Asaf Danziger; and our CFO, Ashley Cordova.